Advertisement

CHEST Physician

Make CHEST Physician® a trusted source
  • Study quantifies reduction in life expectancy for patients with COPD

    Study quantifies reduction in life expectancy for patients with COPD

    Author Surya P. Bhatt, MD, MSPH, said whether newer therapies such as biologics or early-disease interventions can recover lost years remains unknown.


  • Study links birth sites with lower levels of service to higher odds of resuscitation interventions

    Study links birth sites with lower levels of service to higher odds of resuscitation interventions

    While factors such as socioeconomic status and remoteness were not associated with higher odds of interventions, lower-level birth sites were associated with higher odds of chest compressions.


  • Subsolid pulmonary nodules: From guidelines to real-world practice

    Subsolid pulmonary nodules: From guidelines to real-world practice

    The heterogeneity of guidelines on subsolid pulmonary nodules is likely a contributing factor to the discrepancy between published recommendations and real-world practice, but most societies still prioritize nodule size, development of solid component, and change over time.



  • Riot medicine: Treating injuries from nonlethal force

    Riot medicine: Treating injuries from nonlethal force

    At this CHEST 2026 session, a panel of experts will review the most common injury patterns seen in riot medicine and describe the most contemporary approach to their management.


  • Putting radon on your clinical radar

    Putting radon on your clinical radar

    Hear from Clifford Mitchell, MD, MPH, Director of the Environmental Health Bureau at the Maryland Department of Health, about when to test, who is most at risk, and why clinicians should make radon awareness part of routine care.


  • Top reads from the CHEST journal portfolio – August 2026

    Top reads from the CHEST journal portfolio – August 2026

    Read new research from the journal portfolio on fine particulate matter as it relates to incident sleep apnea, respiratory muscle motor control in ventilator weaning, and measuring diagnostic yield in EBUS-TBNA using 19-gauge vs 21- or 22-gauge needles.


  • First-line zongertinib demonstrates durable responses in HER2-mutant NSCLC

    First-line zongertinib demonstrates durable responses in HER2-mutant NSCLC

    Brett Bade, MD, and Katie Smith, MD, said the expansion of targeted therapies for lung cancer is an important advance, while noting that questions remain regarding the drug’s role in the first-line setting.


  • Exercise-induced desaturation common among patients with COPD during early inpatient PR

    Exercise-induced desaturation common among patients with COPD during early inpatient PR

    Michele Vitacca, MD, and Mara Paneroni, PhD, said data show a disconnect between oxygen desaturation and symptom measures, highlighting the importance of objective physiological monitoring.



  • TETON-1 treatment effects offer hope for patients with idiopathic pulmonary fibrosis

    TETON-1 treatment effects offer hope for patients with idiopathic pulmonary fibrosis

    Christopher King, MD, FCCP, and Steven D. Nathan, MD, FCCP, discuss the clinical implications of inhaled treprostinil, including the medication’s potential use in future combination treatment strategies.


  • Study compares antibiotic prescribing in primary care telemedicine vs in-person visits for pediatric ARTIs

    Study compares antibiotic prescribing in primary care telemedicine vs in-person visits for pediatric ARTIs

    Kristin N. Ray, MD, MS, and Samuel R. Wittman, MS, discussed how telemedicine delivered through primary care practices was associated with lower antibiotic use while maintaining guideline-concordant care.